Natco Pharma (India) Buy Hold or Sell Recommendation
| NATCOPHARM | 1,376 38.05 2.84% |
Assuming the 90 days trading horizon and your complete indifference towards market risk, our recommendation regarding Natco Pharma Limited is 'Strong Buy'. The recommendation algorithm takes into account all of Natco Pharma's available fundamental, technical, and predictive indicators you will find on this site.
Check out Natco Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Natco and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Natco Pharma Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Natco |
Execute Natco Pharma Buy or Sell Advice
The Natco recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Natco Pharma Limited. Macroaxis does not own or have any residual interests in Natco Pharma Limited or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Natco Pharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Buy
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Natco Pharma Trading Alerts and Improvement Suggestions
| Natco Pharma Limited generated a negative expected return over the last 90 days | |
| Natco Pharma Limited is unlikely to experience financial distress in the next 2 years | |
| About 51.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: NATCO Pharma Limited Passed Our Checks, And Its About To Pay A 1.50 Dividend - Simply Wall St |
Natco Pharma Returns Distribution Density
The distribution of Natco Pharma's historical returns is an attempt to chart the uncertainty of Natco Pharma's future price movements. The chart of the probability distribution of Natco Pharma daily returns describes the distribution of returns around its average expected value. We use Natco Pharma Limited price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Natco Pharma returns is essential to provide solid investment advice for Natco Pharma.
| Mean Return | -0.15 | Value At Risk | -2.69 | Potential Upside | 3.00 | Standard Deviation | 1.70 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Natco Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Natco Pharma Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (289M) | (2.4B) | 564M | 191M | 424M | 445.2M | |
| Change In Cash | (85M) | 60M | 853M | 208M | 8.2B | 8.6B | |
| Free Cash Flow | 587M | 442M | (2.0B) | 6.4B | 8.9B | 9.4B | |
| Depreciation | 998M | 1.2B | 1.4B | 1.6B | 1.9B | 2.0B | |
| Other Non Cash Items | (605M) | (433M) | (229M) | (2.4B) | 6.9B | 7.2B | |
| Capital Expenditures | 3.6B | 2.5B | 2.4B | 2.1B | 3.6B | 2.0B | |
| Net Income | 5.7B | 5.8B | 2.0B | 8.6B | 13.9B | 14.6B | |
| End Period Cash Flow | 198M | 258M | 1.1B | 1.3B | 9.5B | 10.0B | |
| Dividends Paid | 1.5B | 1.1B | 822M | 1.0B | 1.7B | 1.8B | |
| Investments | 821M | 362M | 2.0B | (4.8B) | (10.3B) | (9.8B) | |
| Net Borrowings | (809M) | (496M) | 1.4B | (2.4B) | (2.2B) | (2.1B) | |
| Change To Netincome | (457M) | (461M) | (347M) | (927M) | (834.3M) | (792.6M) |
Natco Pharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Natco Pharma or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Natco Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Natco stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.21 | |
β | Beta against Dow Jones | 0.39 | |
σ | Overall volatility | 1.67 | |
Ir | Information ratio | -0.17 |
Natco Pharma Volatility Alert
Natco Pharma Limited exhibits very low volatility with skewness of 0.27 and kurtosis of -0.47. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Natco Pharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Natco Pharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Natco Pharma Fundamentals Vs Peers
Comparing Natco Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Natco Pharma's direct or indirect competition across all of the common fundamentals between Natco Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Natco Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Natco Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Natco Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Natco Pharma to competition |
| Fundamentals | Natco Pharma | Peer Average |
| Return On Equity | 0.31 | -0.31 |
| Return On Asset | 0.19 | -0.14 |
| Profit Margin | 0.43 % | (1.27) % |
| Operating Margin | 0.55 % | (5.51) % |
| Current Valuation | 223.82 B | 16.62 B |
| Shares Outstanding | 179.11 M | 571.82 M |
| Shares Owned By Insiders | 50.90 % | 10.09 % |
| Shares Owned By Institutions | 14.39 % | 39.21 % |
| Price To Book | 3.45 X | 9.51 X |
| Price To Sales | 5.40 X | 11.42 X |
| Revenue | 40.02 B | 9.43 B |
| Gross Profit | 20.54 B | 27.38 B |
| EBITDA | 18.8 B | 3.9 B |
| Net Income | 13.88 B | 570.98 M |
| Cash And Equivalents | 4.14 B | 2.7 B |
| Total Debt | 3.86 B | 5.32 B |
| Book Value Per Share | 399.14 X | 1.93 K |
| Cash Flow From Operations | 12.52 B | 971.22 M |
| Earnings Per Share | 108.66 X | 3.12 X |
| Target Price | 1343.09 | |
| Number Of Employees | 4.02 K | 18.84 K |
| Beta | 0.52 | -0.15 |
| Market Capitalization | 246.37 B | 19.03 B |
| Total Asset | 69.06 B | 29.47 B |
| Retained Earnings | 44.66 B | 9.33 B |
| Working Capital | 30.51 B | 1.48 B |
| Annual Yield | 0 % | |
| Net Asset | 69.06 B | |
| Last Dividend Paid | 1.25 |
Natco Pharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Natco . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.0317 | |||
| Daily Balance Of Power | 0.8667 | |||
| Rate Of Daily Change | 1.03 | |||
| Day Median Price | 1362.05 | |||
| Day Typical Price | 1366.53 | |||
| Market Facilitation Index | 43.9 | |||
| Price Action Indicator | 32.48 | |||
| Period Momentum Indicator | 38.05 | |||
| Relative Strength Index | 48.88 |
About Natco Pharma Buy or Sell Advice
When is the right time to buy or sell Natco Pharma Limited? Buying financial instruments such as Natco Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Natco Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Technology Thematic Idea Now
Technology
Companies that are involved in development or distribution of technologically based goods and services such as software, IT or electronics. The Technology theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Technology Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Natco Stock
Natco Pharma financial ratios help investors to determine whether Natco Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Natco with respect to the benefits of owning Natco Pharma security.